Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes. (Q53250655)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

title

Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

Antonio Pagliuca

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Zi Yi Lim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

Aloysius Y L Ho

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

Wendy Ingram

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

Michelle Kenyon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

Laurence Pearce

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

Barbara Czepulkowski

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

Rafael F Duarte

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

Ghulam J Mufti

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

25 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

British Journal of Haematology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

volume

135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

201-209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939494 AND SRC:MED&resulttype=core&format=json

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2006.06272.X